Congress trades
Artivion, Inc. (AORT)
Free on iOS and Android.
About Artivion, Inc.
from the company's filings and listing, as of Oct 20, 2026- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Medical - Devices
- Chief executive
- James Patrick Mackin
- Employees
- 1,800
- Listed since
- Feb 12, 1993
- Market value
- $1.1B
- Price to earnings (12 mo)
- -
- Net income per share, as reported (12 mo)
- -$0.07
- Dividend yield
- -
Earnings
6 reported quarters · next on Nov 5, 2026| Quarter | EPS | EPS expected | Revenue | Revenue expected | Result |
|---|---|---|---|---|---|
| Q2 FY2026reported Aug 6, 2026 | -$0.28 | $0.00 | $125.8M | $120.0M | EPS miss, GAAPRevenue beat |
| Q1 FY2026reported May 7, 2026 | $0.03 | $0.06 | $116.3M | $115.7M | EPS miss, GAAPRevenue in line |
| Q4 FY2025reported Feb 12, 2026 | $0.05 | $0.14 | $116.0M | $116.5M | EPS missRevenue in line |
| Q3 FY2025reported Nov 6, 2025 | $0.16 | $0.14 | $113.4M | $110.4M | EPS beatRevenue beat |
| Q2 FY2025reported Aug 7, 2025 | $0.03 | $0.11 | $113.0M | $108.0M | EPS miss, GAAPRevenue beat |
| Q1 FY2025reported May 5, 2025 | -$0.01 | $0.12 | $99.0M | $94.8M | EPS miss, GAAPRevenue beat |
Actual against the consensus estimate at the time. A flag marks a beat or a miss of more than 1.5% either way; inside that band the quarter is in line. A flag marked GAAP compares a GAAP figure the company reported with an adjusted consensus, two different measures, so a one-time gain or charge can move it either way. A flag reads n/a only when a number is missing. Quarterly EPS is the figure set against the consensus, usually adjusted, so the quarters need not add up to the 12-month net income per share above. An estimate is a forecast made by analysts, not a company target.
Executive pay
as filed for fiscal 2025 · proxy filed Apr 1, 2026| Executive | Salary | Stock awards | Other | Total |
|---|---|---|---|---|
| J. Patrick MackinChairman, President and Chief Executive Officer | $835K | $5.0M | $1.0M | $6.9M |
| Lance A. BerryExecutive Vice President, Chief Operating Officer, Chief Financial Officer, and Treasurer | $526K | $2.0M | $491K | $3.0M |
| John E. DavisSenior Vice President, Chief Commercial Officer | $441K | $1.2M | $282K | $2.0M |
| Jean F. HollowaySenior Vice President, General Counsel, Corporate Secretary, and Chief Compliance Officer | $438K | $1.2M | $281K | $1.9M |
| Marshall S. StantonSenior Vice President, Clinical Research and Chief Medical Officer | $444K | $935K | $281K | $1.7M |
The summary compensation table from the proxy statement for fiscal 2025, with titles as filed then. Executives who have since left are not shown. Read the filing
GetSignal watches Form 4 and STOCK Act filings and pushes each one to your phone as it is published, with the history behind it. Free on iOS and Android.
Congress trades in AORT
8 disclosures of 8 on record · median 26d of the 45 allowedSince the trade: the stock's move from the trade date to the latest close we hold (figures as of Oct 24, 2026), not the member's result. Not investment advice.
| Member | Type | Action | Amount disclosed | Stock since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Gilbert Ray Cisneros, Jr. | Stock | Purchase | $1,001 - $15,000 | -16.7%S&P 500 -0.3% · -16.4 pts vs S&P 500 | Aug 20, 2026 | Sep 10, 2026 | 21d |
| Gilbert Ray Cisneros, Jr.Filed late | Stock | Purchase | $1,001 - $15,000 | -9.4%S&P 500 +1.2% · -10.7 pts vs S&P 500 | Jul 16, 2026 | Sep 4, 2026 | 50d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | -42.3%After the saleS&P 500 +13.2% · -55.5 pts vs S&P 500 | Oct 9, 2025 | Nov 18, 2025 | 40d |
| Tina SmithSpouse | Stock | Purchase | $50,001 - $100,000 | +74.8%S&P 500 +72.6% · +2.3 pts vs S&P 500 | Nov 10, 2023 | Nov 20, 2023 | 10d |
| Tina SmithSpouse | Stock | Purchase | $50,001 - $100,000 | +65.4%S&P 500 +68.9% · -3.5 pts vs S&P 500 | Nov 16, 2023 | Nov 20, 2023 | 4d |
| Josh GottheimerJoint | Stock | Purchase | $1,001 - $15,000 | +48.9%S&P 500 +69.2% · -20.4 pts vs S&P 500 | Jul 14, 2023 | Aug 21, 2023 | 38d |
| Josh GottheimerJoint | Stock | Sale | $1,001 - $15,000 | +44.6%After the saleS&P 500 +74.1% · -29.4 pts vs S&P 500 | Jun 13, 2023 | Jul 11, 2023 | 28d |
| Tina SmithSpouse | Stock | Purchase | $50,001 - $100,000 | +75.1%S&P 500 +105.7% · -30.6 pts vs S&P 500 | Sep 23, 2022 | Oct 17, 2022 | 24d |
Since the trade is an estimate, set beside the S&P 500 over the same window, with the gap between the two in percentage points. The filing carries a band, not a fill, and a sale keeps the stock's sign, so a positive figure after a sale means the stock kept rising after it. An option row carries the underlying stock's move. A row marked n/a is one we hold no figure for.
A delay above 45 days is the gap between the dates on the report; we mark a filing late only after checking it.
"Not captured" means the band or the transaction type on the original report is missing from our data.
"Dates conflict" marks a row whose disclosure is dated before its trade on the record we hold. Both dates are printed as filed, and no since-the-trade figure is computed from them.
Every Congress trade in AORT, filterable by party, chamber, type and account.
Members of Congress reporting a position
3 members · estimate, as of Oct 19, 20263 members report a position (estimated). The largest estimated position is in the $250,001 - $500,000 band.
| Member | Party, chamber | Estimated position | Share of their portfolio |
|---|---|---|---|
| Tina Smith | Democrat · Senate | $250,001 - $500,000 | 20.5% |
| Gilbert Ray Cisneros, Jr. | Democrat · House | $15,001 - $50,000 | 0.1% |
| Josh Gottheimer | Democrat · House | $1,001 - $15,000 | <0.1% |
Estimate, as of Oct 19, 2026. Each position is modelled from the member's disclosed transactions and annual filings: the midpoint of each disclosed band, moved with the stock's price since the trade. It is a rough estimate of a reported position, not a figure from a filing, which is why it is shown as a band. Share of portfolio sets that estimate against the member's whole estimated public-stock portfolio.
Questions
Which members of Congress have traded AORT?
Gilbert Ray Cisneros, Jr., Tina Smith and Josh Gottheimer disclosed AORT transactions in the filings shown here.
Which members of Congress hold AORT?
3 members of Congress report a position in AORT in the estimate we hold as of Oct 19, 2026. The estimated positions belong to Tina Smith, Gilbert Ray Cisneros, Jr. and Josh Gottheimer. The estimate is built from disclosed transactions and annual filings, so it is shown as a band rather than a figure from a filing.
How quickly are AORT trades disclosed?
Congressional disclosures took a median of 26 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Oct 26, 2026.